HEAD Study
Start date:1st August 2019 End date:
31st August 2019 Co-ordinated by:
Julia Grahamslaw
Prospective multicentre observational study conducted over one calendar month in 2019, with a planned sample size of 1000 over 5 sites. The aim of the study was to describe the epidemiology of non-trauma related headache in adults presenting to emergency departments including investigations, treatments and outcome.
This includes adult patients presenting to the ED with non-trauma-related headache as their primary complaint.
This was a study working in collaboration with the Trainee Emergency Medicine Research Network (TERN) to understand the international epidemiology of patients presenting to the ED with a headache.
Research Team
Julia Grahamslaw
Lead Research Nurse
Dr Matt Reed
Director of EMERGE, Consultant, NRS Career Research Fellow & Honorary Reader in Emergency Medicine
Sian Dalgleish
Senior Research Nurse
More EMERGE Trials
TARGET CTCA is a joint venture between EMERGE and the cardiology research team aiming to recruit patients with suspected ACS across NHS Lothian and NHS Greater Glasgow and Clyde. The study aims to recruit 2270 participants. For further information, please contact the EMERGE team.
TARGET-CTCA Trial
ATTEST2 Trial
Alteplase-Tenecteplase Trial Evaluation for Stroke Thrombolysis (ATTEST 2)
Diagnostics devices play an important part in the clinical assessment of a patient’s health and treatment. The purpose of the study is the evaluation of a new diagnostic platform developed by LumiraDx. The evaluation is focused around various biomarkers useful in the emergency settings.
NOVEL Study
Collection of venous and capillary blood samples for the evaluation of new diagnostic devices for cardiovascular conditions